Myasthenia gravis and Lambert-Eaton myasthenic syndrome: treatment options and guidance for management during COVID-19 pandemic
Myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are immune-mediated neurologic disorders characterized by muscle weakness and fatigue. MG is the most common neuromuscular junction disorder while LEMS is an extraordinary rare disease. The symptomatic treatment of MG and LEMS incl...
Saved in:
Main Authors: | A. Klimašauskienė, R. Bunevičiūtė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2020-06-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27748 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Using Intravenous Inmunoglobulin in an Atypical Case of Lambert Eaton Síndrome.
by: Erélido Hernández Valero, et al.
Published: (2007-04-01) -
Case report: Successful perioperative intervention with efgartigimod in a patient in myasthenic crisis
by: Shahar Shelly
Published: (2025-01-01) -
Myasthenia gravis as one of paraneoplastic neurological syndromes associated with small cell lung cancer. Case report
by: R. Bunevičiūtė, et al.
Published: (2018-03-01) -
Multiple Brain Abscesses in a Patient with Myasthenia Gravis – a Case Report
by: S. Radzevičiūtė, et al.
Published: (2023-12-01) -
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk
by: Mohamed Khateb, et al.
Published: (2025-01-01)